Avante Capital Partners, a women-owned private credit and structured equity firm, completed a unitranche debt and equity investment in SSI Strategy Holdings to support a growth investment by Amulet Capital Partners.
Headquartered in Parsipanny, NJ, SSI is a provider of strategic consulting services for scientific functions within life sciences companies.
“SSI’s scientific expertise and client partnership focus has been pivotal to the successful outcomes of high-profile programs in leading cell & gene therapy companies, among other innovative modalities,” Avi Uttamchandani, principal at Amulet Capital Partners, said. “Avante’s flexible and forward-thinking approach aligns perfectly with our needs as we grow the business and solidify SSI’s position as an industry-leading consulting firm focused on the full lifecycle of Life Sciences organizations.”
“We are excited to partner with Amulet alongside SSI’s CEO Douglas Locke and president Adam Schwartz. We are impressed with what Doug and Adam have built and look forward to supporting them and their continued growth,” Jackie Reilly, vice president at Avante Capital Partners.
“And we’re thrilled to support Amulet in their investment. We’re confident that their deep knowledge and experience in the healthcare sector combined with SSI’s innovative service offerings will lead to groundbreaking scientific advances in the future,” Ivelisse Simon, managing partner at Avante Capital Partners, said.